10x Genomics (TXG) Cash from Operations Growth (1y) (2019 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 14.65% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 43.37% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | -14.10% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | 42.90% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | -2.84% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | -15.28% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | 14.53% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | 39.29% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | -4.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.15% |
| Mar 31, 2026 | -23.96% |
| Dec 31, 2025 | 704.28% |
| Sep 30, 2025 | 99.69% |
| Jun 30, 2025 | 136.23% |
| Mar 31, 2025 | 318.45% |
| Dec 31, 2024 | -126.20% |
| Sep 30, 2024 | 185.52% |
| Jun 30, 2024 | 165.04% |
| Mar 31, 2024 | -281.21% |
| Dec 31, 2023 | 87.70% |
| Sep 30, 2023 | -164.58% |
| Jun 30, 2023 | 32.05% |
| Mar 31, 2023 | 80.17% |
| Dec 31, 2022 | 136.40% |
| Sep 30, 2022 | 63.52% |
| Jun 30, 2022 | -643.69% |
| Mar 31, 2022 | -409.60% |
| Dec 31, 2021 | 104.46% |
| Sep 30, 2021 | 52.87% |